Tag: Rob Plesnarski
Cancer drug firm Adlai Nortye raises USD97.5m in Nasdaq IPO
O’Melveny, Han Kun Law Offices, Maples Group, Latham & Watkins and Zhong Lun Law Firm advised on cancer drug developer Adlai Nortye’s Nasdaq debut
O’Melveny, Han Kun Law Offices, Maples Group, Latham & Watkins and Zhong Lun Law Firm advised on cancer drug developer Adlai Nortye’s Nasdaq debut
As mandatory ESG reporting is phased in, green claims may face securities law and cross-border compliance scrutiny. General counsel and environmental lawyers assess the evolving challenges
91视频 senior advocate designation forces partners to leave firms, but reforms may allow continued affiliation
Follow us on LinkedIn